Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. - Kimball,A.B.; Gordon,K.B.; Langley,R.G. (Arch Dermatol, 2008)